Tratamiento con rituximab para las miopatías necrosantes autoinmunes asociadas al anti-SRP: caso clínico y revisión de la evidencia
Author:
Publisher
Elsevier BV
Subject
Rheumatology
Reference10 articles.
1. Human autoantibodies reactive with the signal recognition particle;Reeves;Proc Natl Acad Sci USA,1986
2. Human autoantibodies against the 54kDa protein of the signal recognition particle block function at multiple stages;Romisch;Arthritis Res Ther,2006
3. The 72-kDa component of signal recognition particle is cleaved during apoptosis;Utz;J Biol Chem,1998
4. Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1ß-induced Up-regulation of SRP72 autoantigen in Jurkat cells;Arana-Argáez;J Biol Chem,2010
5. Rituximab in autoimmune diseases;Randall;Aust Prescr,2016
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-signal recognition particle antibody–positive immune-mediated necrotizing myopathy treated with ofatumumab;Rheumatology;2023-08-21
2. Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts;Frontiers in Immunology;2022-10-13
3. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature;Frontiers in Immunology;2021-12-02
4. Report of a case of necrotizing autoimmune myopathy with thymoma-associated myasthenia gravis;International Journal of Neuroscience;2020-02-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3